2 false false false false false false false false false false true false false false false false false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 2,024 2,024 506 506 1,518 xbrli:pure xbrli:shares iso4217:GBP 13302157 2022-07-01 2023-06-30 13302157 2023-06-30 13302157 2022-06-30 13302157 2021-03-31 2022-06-30 13302157 2022-06-30 13302157 2021-03-30 13302157 bus:RegisteredOffice 2022-07-01 2023-06-30 13302157 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 13302157 bus:Director1 2022-07-01 2023-06-30 13302157 bus:Director2 2022-07-01 2023-06-30 13302157 core:WithinOneYear 2023-06-30 13302157 core:WithinOneYear 2022-06-30 13302157 core:AfterOneYear 2023-06-30 13302157 core:ShareCapital 2023-06-30 13302157 core:ShareCapital 2022-06-30 13302157 core:RetainedEarningsAccumulatedLosses 2023-06-30 13302157 core:RetainedEarningsAccumulatedLosses 2022-06-30 13302157 bus:SmallEntities 2022-07-01 2023-06-30 13302157 bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 13302157 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 13302157 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 13302157 bus:FullAccounts 2022-07-01 2023-06-30 13302157 core:OfficeEquipment 2022-07-01 2023-06-30 13302157 core:OfficeEquipment 2023-06-30
COMPANY REGISTRATION NUMBER: 13302157
AB&FS SURGERY LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 June 2023
AB&FS SURGERY LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 30 JUNE 2023
Contents
Page
Officers and professional advisers
1
Statement of financial position
2
Notes to the financial statements
4
AB&FS SURGERY LIMITED
OFFICERS AND PROFESSIONAL ADVISERS
The board of directors
Mr A Bille
Ms F Soggiu
Registered office
Lynton House
7-12 Tavistock Square
London,
England,
UK
WC1H 9BQ
Accountants
TC BSG Valentine Limited
Accountants
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
AB&FS SURGERY LIMITED
STATEMENT OF FINANCIAL POSITION
30 June 2023
2023
2022
Note
£
£
£
£
FIXED ASSETS
Tangible assets
5
1,518
CURRENT ASSETS
Debtors
6
11,452
21,837
Cash at bank and in hand
236,953
133,155
---------
---------
248,405
154,992
CREDITORS: amounts falling due within one year
7
( 41,762)
( 70,390)
---------
---------
NET CURRENT ASSETS
206,643
84,602
---------
--------
TOTAL ASSETS LESS CURRENT LIABILITIES
208,161
84,602
CREDITORS: amounts falling due after more than one year
8
( 20,417)
---------
--------
NET ASSETS
187,744
84,602
---------
--------
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
187,644
84,502
---------
--------
SHAREHOLDERS FUNDS
187,744
84,602
---------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
AB&FS SURGERY LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
30 June 2023
These financial statements were approved by the board of directors and authorised for issue on 21 April 2024 , and are signed on behalf of the board by:
Mr A Bille
Director
Company registration number: 13302157
AB&FS SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 JUNE 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lynton House, 7-12 Tavistock Square, London,, England,, WC1H 9BQ, UK.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. Revenue recognition Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Income tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Tangible assets Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss. Depreciation Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment - 25% straight line
Impairment of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Tangible assets
Equipment
£
Cost
At 1 July 2022
Additions
2,024
-------
At 30 June 2023
2,024
-------
Depreciation
At 1 July 2022
Charge for the year
506
-------
At 30 June 2023
506
-------
Carrying amount
At 30 June 2023
1,518
-------
At 30 June 2022
-------
6. Debtors
2023
2022
£
£
Trade debtors
4,852
21,837
Other debtors
6,600
--------
--------
11,452
21,837
--------
--------
7. Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans and overdrafts
2,917
Corporation tax
34,632
25,673
Other creditors
4,213
44,717
--------
--------
41,762
70,390
--------
--------
8. Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
20,417
--------
----